They found that a VEGF level > 519.8 pg/mL had a significant impact on post-stroke cognitive impairment (PSCI) measured by the Montreal Cognitive Assessment (MoCA)—in particular, a decrease in visuospatial and recall area in the compensatory-regenerative phase of rehabilitation. The gene discussed is VEGFA; the disease is stroke disorder.